Science ❯ Medicine

Drug Development

Clinical Research Targeted Therapy Clinical Trials

FDA Names First 9 Drugs for ‘National Priority’ Fast-Track Reviews, Targeting 1–2-Month Decisions

The pilot prioritizes therapies tied to public health, affordability or U.S. manufacturing; a second round is expected within weeks.

Vertex Halts VX-993 Acute Pain Program After Phase 2 Trial Failure

FDA Names George Tidmarsh Director of Center for Drug Evaluation and Research